Nektar Therapeutics
NKTR
$56.23
-$0.39-0.69%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 568.60M | 245.75M | 270.21M | 175.90M | 218.63M |
| Total Receivables | 3.60M | 1.78M | 1.29M | 1.35M | 1.71M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.78M | 2.20M | 2.36M | 1.73M | 2.21M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 14.06M | 16.54M | 7.50M | 7.58M | 7.36M |
| Total Current Assets | 589.04M | 266.27M | 281.36M | 186.57M | 229.91M |
|
|
|||||
| Total Current Assets | 589.04M | 266.27M | 281.36M | 186.57M | 229.91M |
| Net Property, Plant & Equipment | -- | 5.00M | 10.00M | 10.57M | 11.16M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.24M | 5.65M | 5.16M | 5.02M | 5.39M |
| Total Assets | 763.27M | 280.41M | 301.35M | 207.53M | 256.24M |
|
|
|||||
| Total Accounts Payable | 10.03M | 10.77M | 15.56M | 14.28M | 17.83M |
| Total Accrued Expenses | 22.09M | 19.64M | 25.45M | 31.82M | 28.43M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 22.53M | 20.50M | 22.18M | 22.01M | 21.84M |
| Total Finance Division Other Current Liabilities | 3.07M | 2.63M | 3.15M | 3.28M | 2.83M |
| Total Other Current Liabilities | 3.07M | 2.63M | 3.15M | 3.28M | 2.83M |
| Total Current Liabilities | 57.71M | 53.54M | 66.34M | 71.39M | 70.93M |
|
|
|||||
| Total Current Liabilities | 57.71M | 53.54M | 66.34M | 71.39M | 70.93M |
| Long-Term Debt | 60.27M | 63.16M | 75.16M | 80.57M | 86.32M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 60.63M | 65.26M | 69.73M | 74.15M | 78.50M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.45M | 8.63M | 5.03M | 5.64M | 6.76M |
| Total Liabilities | 187.06M | 190.57M | 216.26M | 231.75M | 242.50M |
|
|
|||||
| Common Stock & APIC | 4.38B | 3.85B | 3.81B | 3.67B | 3.66B |
| Retained Earnings | -3.81B | -3.76B | -3.72B | -3.69B | -3.65B |
| Treasury Stock & Other | -1.03M | 17.00K | 56.00K | -3.01M | -2.96M |
| Total Common Equity | 576.22M | 89.83M | 85.09M | -24.21M | 13.74M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 576.22M | 89.83M | 85.09M | -24.21M | 13.74M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 576.22M | 89.83M | 85.09M | -24.21M | 13.74M |
|
|
|||||